Skip Navigation

skip navigationNIDDK Home
NIDDK Reference Collection
Diet   Exercise   Health  
Home Page
-  

FAQ

Detailed Search

- -
NIDDK INFORMATION SERVICES
- -

Diabetes

Digestive Diseases

Endocrine and Metabolic Diseases

Hematologic Diseases

Kidney and Urologic Diseases

Weight-control Information Network

-
NIDDK EDUCATION
PROGRAMS

- -

National Diabetes Education Program

National Kidney Disease Education Program

-
- - -
NIDDK Home
-
Contact Us
-
New Search
-
Topic: kidney and urologic diseases (ku)
Title: Benign Prostatic Hyperplasia.
Author: Gretzer, M.B.
Source: IN: Kellogg Parsons, J.; James Wright, E., eds. Brady Urology Manual. New York, NY: Informa Healthcare USA. 2006. pp 71-84.
Availability: Available from Informa Healthcare USA. 52 Vanderbilt Avenue, New York, NY 10017. Email: healthcare .enquiries@informa.com. Website: www.informahealthcare .com/. Price: $124.95.
Abstract: This chapter about benign prostatic hyperplasia (BPH) is from a reference handbook that offers a comprehensive overview of urology, presented in outline and bulleted formats for ease of access in the busy health care world of hospital emergency rooms and outpatient clinics. The author defines BPH as uncontrolled, nonmalignant growth of the prostate characterized by hyperplasia of epithelial and stromal cells within the transition zone. The chapter covers prostate anatomy, presentation and epidemiology, etiology, pathophysiology, diagnosis, initial patient evaluation, general principles of treatment, watchful waiting, medical therapy, and minimally invasive therapies, including transurethral microwave therapy (TUMT), transurethral needle ablation (TUNA), prostatic urethral stents, transurethral resection of the prostate (TURP), transurethral electrovaporization of the prostate (TUVP), transurethral incision of the prostate (TUIP), laser ablation, and open prostatectomy. Clinically, BPH typically presents with lower urinary tract symptoms (LUTS). The American Urological Association (AUA) Symptom Index can be used as a measure for grading symptom severity, determining need for therapy, and assessing response to therapy. The authors stress that, due to the variability of the impact of LUTS on quality of life among men with BPH, the patient’s perception of the severity of the condition remains a primary determinant in the selection of management options. The chapter concludes with a list of references for additional reading and an appendix that reprints the AUA symptom index for BPH. 2 appendices. 2 figures. 44 references.

Format: Book Chapter
Language: English.
Major Keywords: Urologic Diseases. Patient Care Management. Symptoms. Risk Factors. Diagnosis. Therapy. Benign Prostatic Hyperplasia.
Minor Keywords: Diagnostic Tests. Pathophysiology. Urinary Tract. Urination Disorders. Watchful Waiting. Drug Therapy. Prostatectomy. Transurethral Resection. Quality of Life.
Publication Number: KUBK11686
Printer-Friendly Version | Return to Search Results
<-- previous record | next record -->

View NIDDK Publications | NIDDK Health Information | Contact Us

The NIDDK Reference Collection is a service of the National Institute of Diabetes and Digestive and Kidney Diseases, National Institutes of Health.
NIDDK Clearinghouses Publications Catalog
5 Information Way
Bethesda, MD 20892–3568
Phone: 1–800–860–8747
TTY: 1–866–569–1162
Fax: 703–738–4929
Email: catalog@niddk.nih.gov

Privacy | Disclaimers | Accessibility | Public Use of Materials
H H S logo - link to U. S. Department of Health and Human Services NIH logo - link to the National Institute of Health NIDDK logo - link to the National Institute of Diabetes and Digestive and Kidney Diseases